We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Abivax Completes Recruitment of ABX464 Phase IIa HIV Study

News   Dec 23, 2015

 
Abivax Completes Recruitment of ABX464 Phase IIa HIV Study
 
 
 

RELATED ARTICLES

Doctors Rely on More Than Just Data During a Diagnosis

News

Computer scientists examine how a doctor’s “gut feeling” influences how many tests they order for patients

READ MORE

UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPO

News

MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).

READ MORE

Novel ALS Therapy in Human Clinical Trials

News

A phase one/two clinical trial has launched to investigate whether a drug could benefit people with ALS whose disease is caused by mutations in a gene called SOD1

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE